Dr. Linkan Laboratories Private Limited
About Dr. Linkan Laboratories Private Limited
Data last updated:
Dr. Linkan Laboratories Private Limited is a private limited company based in Sarai, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 19 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC346222. Its GSTIN is 10AAHCD1079L1ZR (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Mani Bhushan Kumar Ojha and Shashi Bhushan Kumar Ojha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 30 Paryavaran Complex Saidulajab Neb, Sarai, Delhi, India – 110030.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.49 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹1,046 (net margin -0.2%) and EBITDA of ₹2,562 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC – 30 Paryavaran Complex Saidulajab Neb, Sarai, Delhi, India – 110030
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Dr. Linkan Laboratories is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Dr. Linkan Laboratories Private Limited
FY 2025 filings availableDr. Linkan Laboratories Private Limited reported revenue of ₹4.49 Lakh (down 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹2,562 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹1,046 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.6% | |
| Net Profit Margin | -0.2% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dr. Linkan Laboratories are in the company report.
: available in the company report
Board of Directors of Dr. Linkan Laboratories Private Limited
Dr. Linkan Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mani Bhushan Kumar Ojha | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Shashi Bhushan Kumar Ojha | Director | 03 Feb 2020 | 6 Years 8 Months | Current |
Peer Comparison
Dr. Linkan Laboratories Private Limited is compared with the companies closest to it by revenue in the same principal business activity (retail trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Life Time Gift Services Private Limited | ₹4.49 Lakh (FY 2025) | •••• | •••• | 97.0% | •••• | Delhi, India |
| Almentum Healthcare Private Limited | ₹4.49 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Surat, Gujarat, India |
| Anvil Engg Works Pvt Ltd | ₹4.49 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Howrah, West Bengal, India |
| DNP Medical Solutions Private Limited | ₹4.49 Lakh (FY 2023) | •••• | •••• | 6.0% | •••• | Ahmedabad, Gujarat, India |
| Expert Protection Solutions Private Limited | ₹4.49 Lakh (FY 2019) | •••• | •••• | -64.0% | •••• | Delhi, India |
| Dr. Linkan Laboratories Private Limited this company | ₹4.49 Lakh (FY 2025) | •••• | •••• | -43.0% | •••• | Sarai, Delhi, India |
| Tri Swasti Vincom Private Limited | ₹4.49 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Kolkata, West Bengal, India |
| Khemka Technocon Private Limited | ₹4.49 Lakh (FY 2024) | •••• | •••• | 82.0% | •••• | Kolkata, West Bengal, India |
| Wellness Care Pharma Private Limited | ₹4.48 Lakh (FY 2021) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India | |
| Finafid Technologies Private Limited | ₹4.48 Lakh (FY 2023) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Mansa Easy Mart Private Limited | ₹4.48 Lakh (FY 2024) | •••• | •••• | 33.0% | •••• | Bangalore, Karnataka, India |
Peers are the companies nearest to Dr. Linkan Laboratories by revenue, above and below it, in the same principal business activity (retail trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Dr. Linkan Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Dr. Linkan Laboratories.
: available in the company report
Recent Activity
Dr. Linkan Laboratories Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Saurav Kumar ceased to be Director on 03 Feb 2020.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Dr. Linkan Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCD1079L1ZR | Bihar | Active | 10 Aug 2019 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Dr. Linkan Laboratories is an active private limited company based in Sarai, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 19 February 2019 (7+ years old) and is registered under CIN U51909DL2019PTC346222.
Dr. Linkan Laboratories has 2 current directors:
- Mani Bhushan Kumar Ojha - Director
- Shashi Bhushan Kumar Ojha - Director
The latest financial statements of Dr. Linkan Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Dr. Linkan Laboratories is 10AAHCD1079L1ZR, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Dr. Linkan Laboratories is U51909DL2019PTC346222. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Linkan Laboratories was incorporated on 19 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dr. Linkan Laboratories by revenue are Life Time Gift Services Private Limited, Almentum Healthcare Private Limited, Anvil Engg Works Pvt Ltd, DNP Medical Solutions Private Limited, Expert Protection Solutions Private Limited and 5 more, all in the same principal business activity (retail trading).
Saurav Kumar ceased to be Director on 03 Feb 2020. Shashi Bhushan Kumar Ojha was appointed as Director on 03 Feb 2020. Mani Bhushan Kumar Ojha was appointed as Director on 19 Feb 2019.
The registered office of Dr. Linkan Laboratories is at C – 30 Paryavaran Complex Saidulajab Neb, Sarai, Delhi, India – 110030.
Dr. Linkan Laboratories operates in the trading industry, in the specialty segment.
The compliance status of Dr. Linkan Laboratories is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.